- Home
- ABEO vs WHF Comparison
ABEO vs WHF Comparison
Compare ABEO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- WHF
- Stock Information
- Founded
- ABEO N/A
- WHF 2011
- Country
- ABEO United States
- WHF United States
- Employees
- ABEO N/A
- WHF N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- ABEO Health Care
- WHF Finance
- Exchange
- ABEO Nasdaq
- WHF Nasdaq
- Market Cap
- ABEO 237.4M
- WHF 226.2M
- IPO Year
- ABEO 1980
- WHF 2012
- Fundamental
- Price
- ABEO $4.92
- WHF $9.79
- Analyst Decision
- ABEO Strong Buy
- WHF Sell
- Analyst Count
- ABEO 5
- WHF 4
- Target Price
- ABEO $17.00
- WHF $10.83
- AVG Volume (30 Days)
- ABEO 834.1K
- WHF 128.1K
- Earning Date
- ABEO 05-14-2025
- WHF 05-07-2025
- Dividend Yield
- ABEO N/A
- WHF 15.78%
- EPS Growth
- ABEO N/A
- WHF N/A
- EPS
- ABEO N/A
- WHF 0.47
- Revenue
- ABEO N/A
- WHF $92,817,000.00
- Revenue This Year
- ABEO N/A
- WHF N/A
- Revenue Next Year
- ABEO $539.93
- WHF N/A
- P/E Ratio
- ABEO N/A
- WHF $20.91
- Revenue Growth
- ABEO N/A
- WHF N/A
- 52 Week Low
- ABEO $3.05
- WHF $8.44
- 52 Week High
- ABEO $8.45
- WHF $13.44
- Technical
- Relative Strength Index (RSI)
- ABEO 51.29
- WHF 55.60
- Support Level
- ABEO $3.93
- WHF $8.44
- Resistance Level
- ABEO $5.02
- WHF $9.20
- Average True Range (ATR)
- ABEO 0.41
- WHF 0.36
- MACD
- ABEO 0.06
- WHF 0.11
- Stochastic Oscillator
- ABEO 90.83
- WHF 98.54
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.